Paraquat Lawsuit [November 2026 Update] | Parkinson's Claims

Paraquat is a highly toxic herbicide first introduced in the 1960s and widely adopted in U.S. agriculture for weed control and crop management.

Over time, concerns about pesticide exposure mounted as researchers and regulators examined its acute toxicity and long-term health effects.

While Paraquat remains approved for restricted use in the United States, it has been banned in more than 70 countries due to risks associated with accidental ingestion, occupational exposure, and neurological harm.

Scientific studies published over the past two decades have reported an association between Paraquat exposure and a significantly higher risk of developing Parkinson’s disease, particularly among individuals with repeated or occupational contact.

A widely cited National Institutes of Health study found that individuals exposed to Paraquat had a 2.5-times greater risk of Parkinson’s disease compared to those without exposure.

Additional research from the Parkinson’s Institute and Clinical Center has supported these findings, linking Paraquat’s neurotoxic properties to the type of dopaminergic neuron damage seen in Parkinson’s patients.

These findings have fueled nationwide Paraquat litigation, with agricultural workers, applicators, and others filing claims after being diagnosed with Parkinson’s disease.

Paraquat lawsuits allege that manufacturers knew or should have known about these risks but failed to take adequate steps to protect human health.

Plaintiffs argue that the product’s labeling and warnings did not accurately reflect the neurological dangers associated with long-term exposure.

Specifically, Paraquat lawsuits allege that manufacturers and distributors, including Syngenta and Chevron, engaged in conduct that exposed users to unreasonable risk, including:

• Failing to warn users about the link between Paraquat and Parkinson’s disease despite emerging scientific evidence
• Continuing to market and sell Paraquat as safe for use when handled according to instructions, despite evidence of neurological harm
• Downplaying or disregarding data showing elevated Parkinson’s rates among individuals with occupational pesticide exposure
• Prioritizing commercial use and market access over reformulation, additional safety measures, or stronger warnings

Because of the volume of claims and shared factual questions, federal Paraquat cases have been consolidated into multidistrict litigation to coordinate discovery, expert rulings, and pretrial proceedings.

This structure allows the court to address common issues while preserving each plaintiff’s right to pursue an individual claim.

If you have been exposed to Paraquat and were subsequently diagnosed with Parkinson’s disease, you may be eligible to file a Paraquat Lawsuit and pursue compensation for the losses that you incurred from your injuries.

Contact TorHoerman Law to speak with our Paraquat Lawyers and to get a free consultation.

TorHoerman Law’s Paraquat Lawyers are currently presiding in leadership roles for the Paraquat Litigation.

How Many Paraquat Lawsuits Have Been Filed? Current Status of the Paraquat Parkinson’s Disease MDL

The Paraquat Parkinson’s Disease MDL continues to grow, with more than 6,000 pending Paraquat Lawsuits filed.

New Paraquat Lawsuits are currently being filed by lawyers across the country.

Paraquat Lawsuit Updates and Status

The Paraquat litigation continues to develop through both the federal MDL and state court actions, reflecting a dynamic phase in the broader effort to resolve thousands of personal injury claims alleging a link between pesticide exposure and Parkinson’s disease.

The federal multidistrict litigation initially set its first Paraquat bellwether trial for October 2025, but that schedule was delayed as settlement discussions and procedural stays took precedence, pushing active trial timing into early 2026.

In parallel, a Paraquat trial in the Philadelphia state court system was scheduled for January 26, 2026, marking a highly anticipated step toward public examination of key evidence in this mass tort program.

On January 29, 2026, Syngenta and Chevron reached a pre-trial settlement in the first Paraquat case slated to go to trial in Philadelphia court, resolving the matter just before opening statements were to begin; the specific amount of that settlement remains confidential but commentators describe it as significant given the timing.

This pre-trial resolution signals defendants’ willingness to avoid presenting contested causation and warning evidence before a jury, a strategy that may influence settlement negotiations in both federal and state venues.

In another key procedural development, a Pennsylvania appeals court agreed to hear an appeal by Paraquat manufacturers challenging whether certain cases should remain in Philadelphia, an issue that could affect venue and case processing in the statewide docket.

Additionally, the U.S. Supreme Court declined to review a challenge to Pennsylvania’s consent-by-registration statute, leaving in place a law that permits Paraquat cases to proceed in that state rather than be dismissed on jurisdictional grounds.

Though the first federal MDL bellwether was postponed, the litigation has not slowed, with discovery, expert disputes, and settlement dialogues ongoing.

As 2026 progresses, future bellwether trial dates and appellate outcomes (including venue challenges and dispositive motions) will continue to shape how product liability lawsuits in this mass tort context move toward resolution, potentially informing global settlement frameworks for plaintiffs alleging Paraquat-related harm.

Paraquat lawsuits are evaluated on an individual basis within the federal MDL, with no uniform settlement amount applied across all claims.

Unlike class actions, this litigation involves thousands of pending cases that are assessed based on their own medical, occupational, and evidentiary records.

As a result, potential settlement outcomes vary widely depending on the strength of proof and the severity of Parkinson’s disease symptoms alleged in each case.

A strong Paraquat claim generally relies on robust documentation linking pesticide exposure to diagnosis, including medical records, employment history, and evidence showing the duration and nature of Paraquat use.

In product liability lawsuits involving toxic exposure, damages commonly sought include past and future medical expenses, lost wages, diminished earning capacity, and pain and suffering.

In many Paraquat cases, estimated settlement discussions have centered around figures in the $100,000 to $150,000 range, though outcomes may fall well above or below that level depending on individual circumstances.

Based on prior toxic exposure litigation, including a 2017 settlement in which Syngenta and Chevron agreed to pay $187.5 million to resolve claims brought by seven men with Parkinson’s disease, compensation in Paraquat cases has historically reflected both injury severity and evidentiary strength.

Across the current litigation, the average Paraquat settlement amount may range from tens of thousands to several hundred thousand dollars, with some severely affected individuals potentially receiving $1 million or more.

As the MDL progresses and settlement frameworks continue to develop, expected Paraquat settlement amounts are likely to fluctuate, with estimates spanning from approximately $20,000 to over $1.5 million per plaintiff in the most serious cases.

The tiers below illustrate how settlement ranges may be structured in a global resolution, with compensation scaled according to factors such as disease progression, length of exposure, and the quality of supporting medical and occupational evidence.

Settlement outcomes in the Paraquat MDL will ultimately depend on how the court resolves key issues, how defendants structure any global agreement, and how individual claims are evaluated within that framework.

Anyone considering a claim should understand that these figures are estimates, not guarantees, and that outcomes will vary as the litigation involving these pending cases continues to evolve.

Tier 1: Severe Parkinson’s Disease With Extensive Exposure

Estimated Range: $200,000 to $1 million or more

This tier typically involves individuals with advanced Parkinson’s disease, significant functional impairment, and long-term or high-intensity Paraquat exposure.

Claims in this category often include substantial medical expenses, documented loss of income or future earning capacity, and strong causation evidence supported by detailed work history and treating physician records.

In severe cases, compensation may exceed $1 million, particularly where disease progression has resulted in permanent disability or the need for ongoing care.

Tier 2: Moderate Parkinson’s Disease With Documented Occupational Exposure

Estimated Range: $75,000 to $200,000

Tier 2 claims generally involve confirmed Parkinson’s diagnoses with measurable but less debilitating impairment. Exposure histories are often occupational and well-documented, though disease severity and economic losses may be more limited than Tier 1 cases. Many settlement estimates reported in Paraquat litigation discussions, including figures around $100,000 to $150,000, fall within this tier.

Tier 3: Lower-Exposure or Less Severe Injury Claims

Estimated Range: $20,000 to $75,000

This tier may include claims with shorter exposure durations, less extensive documentation, or earlier-stage Parkinson’s disease with minimal economic loss. While still viable personal injury claims, these cases often involve narrower damages and greater evidentiary challenges, which can affect valuation in any global settlement structure.

Paraquat dichloride (paraquat) is a toxic chemical agent most commonly used as an herbicide.

Although it was first produced more than 130 years ago, its application as an herbicide did not become popularized until the mid-20th century.

Paraquat is now used as an herbicide agent on a range of more than 100 different types of crops.

Paraquat is widely used as an herbicide (plant killer), primarily for weed and grass control.

In the United States, Paraquat is available in various strengths and most widely sold in its liquid form.

Is Paraquat Safe?

According to the American Council on Science and Health, Paraquat’s relative toxicity of glyphosate, another popularly used herbicide known to be toxic, ranges from 33-250.

A lethal dose for an average person is around 2.5 grams, and it is even more toxic when inhaled.

Paraquat poisoning is also possible from skin exposure.

According to the Centers for Disease Control (CDC), Paraquat causes direct damage when it comes in contact with the lining of the mouth, stomach, or intestines.

After Paraquat enters the body, it is distributed to all areas of the body and causes toxic chemical reactions to occur in primarily the lungs, liver, and kidneys.

Paraquat’s toxicity has made it a traditionally popular agent for suicide because it can kill a person with a single sip.

Paraquat exposure has also been linked to adverse health effects, including Parkinson’s disease.

Several countries, including the entirety of the European Union (EU) and the United Kingdom, ban Paraquat for use in agriculture, citing the risks of chronic exposure to the herbicide.

Researchers have found that Paraquat exposure leads to an increased risk of developing Parkinson’s disease, a progressive nervous system disorder.

In February 2011, the National Institute of Health (NIH) conducted a study – the Farming and Movement Evaluation (FAME) – exploring claims that exposure to the popular herbicide Paraquat could be linked to a greater risk of developing Parkinson’s disease.

Following the study’s release, Syngenta, a Swiss herbicide manufacturer, claimed on its website that data from the study showed that farmers who use Paraquat are less likely to develop Parkinson’s disease than the general population.

This claim was highly debated by the study’s authors, who attested that the data from the study showed that individuals were roughly two and a half times more likely to develop Parkinson’s after being exposed to Paraquat (or a similar herbicide – Rotenone).

FAME Study Finds Paraquat Parkinson’s Disease Risk

FAME drew data from the Agricultural Health Study, a larger project that tracked more than 80,000 farmers, agricultural workers, and their spouses.

FAME researchers identified 115 individuals who had developed Parkinson’s, studying 110 of these individuals who were open to providing information on the herbicide they frequently used.

Syngenta held the findings in contention, arguing that because only 115 individuals developed Parkinson’s out of more than 80,000 North Carolinians and Iowans included in the Agricultural Health Study, direct correlation between Paraquat and an increased risk of developing Parkinson’s could not be proven.

“The incidence of Parkinson’s disease [in the study] appears to be lower than in the general U.S. population,” explained Syngenta, trying to rationalize their website’s claim.

Dr. Caroline M. Tanner, the director of the Parkinson’s Disease Research, Education and Clinical Centers at the San Francisco Veterans Affairs Medical Center and the lead author of the FAME study explained that Syngenta’s argument held no basis.

Tanner argued that FAME was not a comprehensive assessment of the incident Parkinson’s among all 80,000 individuals.

Rather, the study chose a group of people who did have Parkinson’s – studying that specific group against a control group.

In actuality, FAME relied on self-reporting from participants of the larger Agricultural Health Study.

“There were probably quite a few people with Parkinson’s disease who did not enroll in our study,” explained Dr. Freya Kamel, a scientist at the National Institute of Environmental Health Sciences, a branch of the National Institutes of Health and a co-author of the FAME study.

Syngenta said it “went to significant lengths to attempt to access the data” from the FAME study so that the manufacturer could “gain as complete an understanding as possible of the study in the pursuit of scientific rigor.”

Kamel called Syngenta’s analysis inappropriate.

Kamel found the FAME study data linking Paraquat to Parkinson’s “about as persuasive as these things can get.”

A similar study conducted in 2012 – the Genetic Modification of the Association of Paraquat and Parkinson’s Disease – found that individuals who used Paraquat and who also had a specific genetic variation were 11 times more likely to develop Parkinson’s, indicating that some people are put at greater risk by being exposed to the chemical.

New Research on Paraquat and Parkinson’s Disease Backs FAME Findings

A December 2016 study published in Nature Chemical Biology reassures researchers who believe Paraquat to cause Parkinson’s Disease.

A CRISPR screen, an investigation into the possible agents that increase the risk of Parkinson’s for individuals exposed to Paraquat, identified a pathway required for Paraquat-induced cell death in humans.

The study found that after being exposed to Paraquat, genes that may lead to Parkinson’s disease were identified using an innovative gene-editing technique.

Further, the study found that Paraquat kills cells through a mechanism called oxidative stress.

The study was unable to reveal the exact process that allowed the herbicide to do so, though the researchers presented multiple theories.

Increased Paraquat Use In The United States

In recent years, Paraquat has become a popular alternative to Monsanto’s Roundup in the United States.

Roundup has long been the preferred herbicidal agent for American agricultural workers, but as weeds and pests are becoming more resistant to it, and lawsuits alleging dangers and injuries arise, farmers are turning to alternative herbicides and pesticides to treat their crops.

Paraquat has become the preferred herbicidal alternative, in light of the issues surrounding Roundup, especially for soybean fields, where the number of pounds used is up fourfold over the last 10 years.

In 2016 alone, the United States sprayed 7 million lbs. of Paraquat over nearly 15 million acres of land.

However, it is important to note that all Paraquat products are Restricted Use Pesticides (RUPs), meaning only licensed applicators are able to purchase and use the herbicide.

All applicators must be “licensed in accordance with EPA regulations and state, territorial and tribal laws.”

The U.S. Environmental Protection Agency (EPA) has classified Paraquat as highly toxic to humans, noting that even a small sip can be fatal, with no known antidote available.

Beyond acute poisoning, studies have suggested a potential link between Paraquat exposure and the development of Parkinson’s disease, raising significant public health concerns.

In response, the EPA has implemented stricter regulations, including limiting application methods and requiring specialized training for certified applicators, to mitigate these risks.

Despite these measures, the herbicide’s continued use remains a topic of debate among health professionals and environmentalists.

Paraquat exposure has been found to increase the risk for several health problems, including the following:

• Parkinson’s Disease
• Kidney failure
• Heart failure
• Liver failure
• Lung scarring

Paraquat Poisoning Symptoms and Side Effects

Ingesting or inhaling Paraquat can cause Paraquat poisoning.

Symptoms of Paraquat poisoning are sometimes severe and often hard to ignore.

Paraquat poisoning symptoms and side effects include:

• Tongue sores and mouth ulcers
• Pain in the mouth and throat
• Bleeding in the mouth and throat
• Vomiting
• Stomach pain and cramping
• Blood clots
• Cell death
• Tissue death
• Lung cysts
• Lung collapse
• Dehydration
• Mineral salt imbalance
• Low blood pressure
• Fast heart rate
• Trouble breathing
• Muscle weakness
• Confusion
• Seizures
• Coma
• Other health problems

In March 2016, the Environmental Protection Agency (EPA) announced in a regulatory filing that they would be further exploring the possible health risks associated with Paraquat.

The filing is part of a program, sponsored by the EPA, that re-evaluates all pesticides on a 15-year cycle.

In the announcement, the agency said, “There is a large body of epidemiology data on paraquat dichloride use and Parkinson’s disease.”

In August 2021, the Environmental Protection Agency (EPA) finalized new safety measures for Paraquat use in the United States.

The EPA did not outright ban Paraquat, but outlined the mitigation measures listed below:

• Limiting aerial applications and requiring residential buffers.
• Prohibiting pressurized handgun and backpack sprayer applications.
• Requiring enclosed cabs or respirators for groundboom applications.
• Increasing the Restricted Entry Interval (REI) for several crops.

Scientific research has continually linked Paraquat exposure to an increased risk of developing Parkinson’s disease.

Parkinson’s disease often leads to progressive motor impairment, causing tremors, stiffness, and difficulty with balance that severely impacts day-to-day functioning.

Beyond physical symptoms, many individuals also experience cognitive changes and emotional challenges, which can diminish independence and strain relationships with loved ones.

If you’ve been exposed to the toxic weed killer Paraquat and diagnosed with Parkinson’s disease, you may be eligible to file a Paraquat claim and join the Paraquat Products Liability Litigation.

Contact an experienced Paraquat Lawsuit attorney at TorHoerman Law for a free consultation.

Use the chat feature on this page to find out if you’re eligible to file a Paraquat Lawsuit instantly.

An experienced Paraquat Lawyer can help individuals throughout the legal process, completing all necessary steps including gathering evidence and assessing damages.

Gathering Evidence for Paraquat Parkinson’s Disease Lawsuits

Proving Paraquat exposure is highly important when pursuing a Paraquat Lawsuit.

Sufficient evidence of prolonged exposure to Paraquat and a Parkinson’s disease diagnosis are necessary to successfully pursue a Paraquat claim.

An experienced Paraquat Lawsuit attorney can help you gather, retain, and organize evidence to present your case clearly and effectively.

Potential evidence in your Paraquat Lawsuit may include:

• Medical Records: Documentation of your Parkinson’s disease diagnosis, symptoms, and treatments, establishing a clear timeline of your health impacts.
• Employment Records: Proof of work history in agriculture or other industries where Paraquat exposure was likely, verifying occupational exposure.
• Purchase or Application Records: Receipts, invoices, or application logs showing the purchase or use of Paraquat-containing products.
• Witness Statements: Testimonies from colleagues, family members, or others who can confirm your use of or exposure to Paraquat over time.
• Medical Expert Testimony: Opinions from healthcare professionals linking your Parkinson’s diagnosis to potential exposure to Paraquat.
• Toxicology Reports: Lab results or assessments showing chemical traces consistent with Paraquat exposure.
• Training Certifications: Documentation verifying your credentials to handle Paraquat, as the herbicide is restricted to certified applicators.

Assessing Damages in Paraquat Lawsuits

In a legal context, “damages” refer to the financial compensation awarded to an individual who has suffered harm due to another party’s actions or negligence.

For Paraquat Lawsuits, damages are intended to address the substantial physical, emotional, and financial toll associated with a Parkinson’s disease diagnosis linked to Paraquat exposure.

These damages seek to support individuals and their families by compensating for medical expenses, lost income, and other profound impacts on quality of life.

Damages in Paraquat Lawsuits may include:

• Medical Expenses: Compensation for past, ongoing, and future medical costs related to treating Parkinson’s disease, including medication, therapy, and specialized care.
• Lost Wages and Earning Capacity: Recovery of lost income due to time off work and the diminished ability to work in the future, acknowledging the limitations Parkinson’s places on employment.
• Pain and Suffering: Financial recognition of the physical and emotional pain endured as a result of the disease, impacting daily life and well-being.
• Loss of Enjoyment of Life: Compensation for the reduced ability to participate in activities and hobbies that previously brought enjoyment and fulfillment.
• Caretaking Costs: Coverage for expenses associated with in-home care, assisted living, or family support due to the debilitating effects of Parkinson’s.
• Punitive Damages: In cases of severe negligence or willful misconduct by the manufacturers, additional damages may be awarded to penalize responsible parties and deter future harm.

You are not alone.

There are resources and support groups available for people suffering from the effects of Parkinson’s Disease.

Help, support, and advice for those diagnosed with Parkinson’s Disease are only a click away:

• Parkinson’s Foundation
• American Parkinson’s Disease Association
• The Michael J. Fox Foundation
• PAN Foundation
• Johns Hopkins Parkinson’s Disease and Movement Disorders Center
• Brain Center Parkinson’s Resources

The Paraquat Lawsuit filed in federal court seeks to hold manufacturers accountable for failing to warn about the herbicide’s potential link to Parkinson’s disease and to secure compensation for individuals harmed by prolonged exposure to this toxic chemical.

Our legal team is actively involved in the Paraquat Parkinson’s Lawsuit, reviewing claims from individuals and helping them join the active litigation to pursue financial compensation.

The Paraquat Lawyers at TorHoerman Law work on a contingency fee basis, meaning that we do not charge for legal services unless compensation is won for our clients.

If you’ve been exposed to Paraquat and subsequently diagnosed with Parkinson’s disease, you may be eligible to file a Paraquat Lawsuit.

Contact the Paraquat Attorneys at TorHoerman Law for a free, no-obligation consultation.

Use the chat feature on this page for an instant case evaluation to find out if you’re eligible to file a Paraquat Lawsuit instantly.